findmyKOL
Clinical trialNCT03891615UnknownPhase 1Interventional

Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer

SponsorMassachusetts General HospitalEnrollment30Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This research study is studying a combination of drugs as a possible treatment for EGFR-Mutated Advanced Lung Cancer. The names of the study drugs involved in this study are Niraparib and Osimertinib.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Beth Israel Deaconess

    Boston, Massachusetts, United States

    Daniel Costa, MD
    Recruiting
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Michael Cheng, MD
    Recruiting
  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, United States

    Henning Willers, MDZofia Piotrowska, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Niraparib →Osimertinib →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Jun 2019
Primary completion
30 Apr 2022
Completion
30 Apr 2024
Last update posted
16 Dec 2020
Registered enrollment
30
Registry id
NCT03891615
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.